\
&
Contact us
Published on | 3 years ago
ProgrammesThe Hop On Facility call (HORIZON-WIDERA-2022- ACCESS-07) second cut-off closed on the 10/11/2022 and 81 proposals have been submitted.
Evaluation results are expected to be communicated in March 2023.
Source: Funding and Tenders Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
On 28 January 2026, the SECURE project has launched a first round of financial support measures to help small businesses achieve compliance with new cybersecurity requirements for their hardware and software products. This will allow micro, small and medium enterprises (MSMEs) to request co-funding to strengthen the cybersecurity of their hardware... read more
Climate, Energy, Mobility Horizon Europe HorizonEU L+F
The well-known Excel template used to prepare and submit the detailed budget in lump sum proposals will be successively replaced in the course of 2026 by an online detailed budget table, integrated directly in the Part A application forms. The new format is currently used in 9 topics in Cluster 5 (see list below). When preparing the project proposa... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.